Nikolas Dovrolis
Overview
Explore the profile of Nikolas Dovrolis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dovrolis N, Spathakis M, Collins A, Pandey V, Uddin M, Anderson D, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766077
Background/objectives: The role of the gut microbiome in cancer biology has become an increasingly prominent area of research, particularly regarding the role of microbial metabolites and their receptors (MMRs). These...
2.
Legaki E, Dovrolis N, Moscholiou N, Koutromanos I, Vassilopoulos E, Dakanalis A, et al.
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39518903
Alcohol use disorder's complexity arises from genetic and environmental factors, with alcohol metabolism genes and neurotransmitter pathways being critical. This study aims to analyze synaptic plasticity gene expression changes in...
3.
Drygiannakis I, Valatas V, Filidou E, Tzenaki N, Archontoulaki E, Dovrolis N, et al.
Dig Dis Sci
. 2024 Sep;
69(10):3773-3785.
PMID: 39322807
Background: Ulcerative colitis (UC) increases the risk for venous thromboembolism. Tissue factor (TF) initiates the extrinsic coagulation pathway (ECP). Aims: To investigate the correlation of UC severity with latent ECP...
4.
Dovrolis N, Valatas V, Drygiannakis I, Filidou E, Spathakis M, Kandilogiannakis L, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200138
Background And Aims: Monocyte recruitment in the lamina propria and inflammatory phenotype driven by the mucosal microenvironment is critical for the pathogenesis of inflammatory bowel disease. However, the stimuli responsible...
5.
Dovrolis N, Gazouli M, Rigal F, Whittaker R, Matthews T, Georgiou K, et al.
Gut Pathog
. 2024 Jul;
16(1):34.
PMID: 38972996
It has recently been proposed that the study of microbial dynamics in humans may gain insights from island biogeographical theory. Here, we test whether the diversity of the intratumoral microbiota...
6.
Bampali M, Kouvela A, Kesesidis N, Kassela K, Dovrolis N, Karakasiliotis I
Viruses
. 2024 May;
16(5).
PMID: 38793693
Subgenomic flaviviral RNAs (sfRNAs) are small non-coding products of the incomplete degradation of viral genomic RNA. They accumulate during flaviviral infection and have been associated with many functional roles inside...
7.
Koustenis K, Dovrolis N, Viazis N, Ioannou A, Bamias G, Karamanolis G, et al.
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791570
Introduction: Optimizing treatment with biological agents is an ideal goal for patients with ulcerative colitis (UC). Recent data suggest that mucosal inflammation patterns and serum cytokine profiles differ between patients...
8.
Sidiropoulos T, Dovrolis N, Katifelis H, Michalopoulos N, Kokoropoulos P, Arkadopoulos N, et al.
Biomedicines
. 2024 May;
12(5).
PMID: 38791002
Pancreatic cancer (PC) ranks as the seventh leading cause of cancer-related deaths, with approximately 500,000 new cases reported in 2020. Existing strategies for early PC detection primarily target individuals at...
9.
Kokkotis G, Filidou E, Tarapatzi G, Spathakis M, Kandilogiannakis L, Dovrolis N, et al.
Inflamm Bowel Dis
. 2024 May;
30(11):2162-2173.
PMID: 38717842
Background: Oncostatin-M (OSM) is associated with antitumor necrosis factor (anti-TNF)-α resistance in inflammatory bowel disease (IBD) and fibrosis in inflammatory diseases. We studied the expression of OSM and its receptors...
10.
Spathakis M, Dovrolis N, Filidou E, Kandilogiannakis L, Tarapatzi G, Valatas V, et al.
Pharmaceuticals (Basel)
. 2024 Apr;
17(4).
PMID: 38675452
Metabolites produced by dysbiotic intestinal microbiota can influence disease pathophysiology by participating in ligand-receptor interactions. Our aim was to investigate the differential expression of metabolite receptor (MR) genes between inflammatory...